CFO at IRLAB Therapeutics, listed at Nasdaq Stockholm Main Market. MSc (Finance) and lawyer with over 25 years of experience from transactions, negotiations, capital markets, corporate governance, investor relations, financial reporting and management positions.🔍 Background and Expertise: With experience as a CFO, M&A, financial advisor, board member and investor, I specialize in maximizing potential. With relevant education and experience from transactions and corporate governance, I add value and strategic focus to public companies or companies that aim to become listed. 📊 Responsibilities at IRLAB: At IRLAB, I've handled a full range of financial responsibilities, including financing, financial reporting, internal control, investor relations, capital market connections, and ensuring corporate governance compliance.📈 Listing Achievements: I played a pivotal role in listing IRLAB on Nasdaq Stockholm main market in 2020 and Nasdaq First North Premier Growth Market in 2017. Over the years, I've successfully secured around SEK 750 million (EUR 70 million) in financing to IRLAB.🤝 Beyond IRLAB: My expertise extends to advising and leading projects in areas such as mergers and acquisitions, business development, deal structuring, and complex financing solutions. My experience spans various sectors, from wind power to IT startups and biotech firms.🎓 Educational Foundation: I hold a Master of Law (LLM) and a Master of Science in Financing from the Gothenburg School of Business, Economics, and Law. Focus has been on corporate and contract law as well as accounting and financing. This educational background equips me with a unique perspective on the challenges faced by companies that aim to grow.